The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer
Open accessAbstract
BACKGROUND: The incidence of anal cancer is substantially higher among persons living with the human immunodeficiency virus (HIV) than in the general population. Similar to cervical cancer, anal cancer is preceded by high-grade squamous intraepithelial lesions (HSILs). Treatment for cervical HSIL reduces progression to cervical cancer; however, data from prospective studies of treatment for anal HSIL to prevent anal cancer are lacking. METHODS: We conducted a phase 3 trial at 25 U.S. sites. Persons living with HIV who were 35 years of age or older and who had biopsy-proven anal HSIL were randomly assigned, in a 1:1 ratio, to receive either HSIL treatment or active monitoring without treatment. Treatment included office-based ablative procedures, ablation or excision under anesthesia, or the administration of topical fluorouracil or imiquimod. The primary outcome was progression to anal cancer in a time-to-event analysis. Participants in the treatment group were treated until HSIL was completely resolved. All the participants underwent high-resolution anoscopy at least every 6 months; biopsy was also performed for suspected ongoing HSIL in the treatment group, annually in the active-monitoring group, or any time there was concern for cancer. RESULTS: Of 4459 participants who underwent randomization, 4446 (99.7%) were included in the analysis of the time to progression to cancer. With a median follow-up of 25.8 months, 9 cases were diagnosed in the treatment group (173 per 100,000 person-years; 95% confidence interval [CI], 90 to 332) and 21 cases in the active-monitoring group (402 per 100,000 person-years; 95% CI, 262 to 616). The rate of progression to anal cancer was lower in the treatment group than in the active-monitoring group by 57% (95% CI, 6 to 80; P = 0.03 by log-rank test). CONCLUSIONS: Among participants with biopsy-proven anal HSIL, the risk of anal cancer was significantly lower with treatment for anal HSIL than with active monitoring. (Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT02135419.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70103-7 · Cited by 1,123
Machalek, D. A., Poynten, M., Jin, F., Fairley, C. K., Farnsworth, A., Garland, S. M., Hillman, R. J., Petoumenos, K., Roberts, J., Tabrizi, S. N., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70080-3 · Cited by 963
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
Palefsky, J. M., Giuliano, A. R., Goldstone, S., Moreira, E. D., Aranda, C., Jessen, H., Hillman, R., Ferris, D., Coutlee, F., Stoler, M. H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010971 · Cited by 948
Self-citationDarragh, T. M., Colgan, T. J., Thomas Cox, J., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2013) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31826916c7 · Cited by 571
Self-citationHuman papillomavirus type distribution in anal cancer and anal intraepithelial lesions
Hoots, B. E., Palefsky, J. M., Pimenta, J. M., & Smith, J. S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24215 · Cited by 461
Self-citationBray, F., Loos, A. H., McCarron, P., Weiderpass, E., Arbyn, M., Møller, H., Hakama, M., & Parkin, D. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0569 · Cited by 370
Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials
Lakatos, E. (1988) · Biometrics · doi:10.2307/2531910 · Cited by 350
Deshmukh, A. A., Suk, R., Shiels, M. S., Sonawane, K., Nyitray, A. G., Liu, Y., Gaisa, M. M., Palefsky, J. M., & Sigel, K. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz219 · Cited by 327
Self-citationAnal Cancer Incidence: Genital Warts, Anal Fissure or Fistula, Hemorrhoids, and Smoking
Holly, E. A., Whittemore, A. S., Aston, D. A., Ahn, D. K., Nickoloff, B. J., & Kristiansen, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.22.1726 · Cited by 262
Metadata
- Authors
- Palefsky, J. M., Lee, J. Y., Jay, N., Goldstone, S. E., Darragh, T. M., Dunlevy, H. A., Rosa-Cunha, I., Arons, A., Pugliese, J. C., Vena, D., Sparano, J. A., Wilkin, T. J., Bucher, G., Stier, E. A., Tirado Gomez, M., Flowers, L., Barroso, L. F., Mitsuyasu, R. T., Lensing, S. Y., Logan, J., Aboulafia, D. M., Schouten, J. T., de la Ossa, J., Levine, R., Korman, J. D., Hagensee, M., Atkinson, T. M., Einstein, M. H., Cracchiolo, B. M., Wiley, D., Ellsworth, G. B., Brickman, C., & Berry-Lawhorn, J. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-06-16
- Volume
- 386
- Issue
- 24
- Pages
- 2273-2282
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4282974371
- Cited by
- 512
- References
- 32
- FWCI
- 89.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer. https://app.cochat.ai/papers/10.1056/nejmoa2201048
- The paper
- Palefsky, J. M., Lee, J. Y., Jay, N., Goldstone, S. E., Darragh, T. M., Dunlevy, H. A., Rosa-Cunha, I., Arons, A., Pugliese, J. C., Vena, D., Sparano, J. A., Wilkin, T. J., Bucher, G., Stier, E. A., Tirado Gomez, M., Flowers, L., Barroso, L. F., Mitsuyasu, R. T., Lensing, S. Y., . . . Berry-Lawhorn, J. M. (2022). Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2201048
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.